Among nonpregnant women of reproductive age in the US, the prevalence of chronic hypertension (cHTN) is approximately 9%, and hypertensive disorders of pregnancy complicate approximately 5% of all pregnancies.1 Although most pregnancies among individuals with well-controlled cHTN are uncomplicated, individuals with cHTN are at increased risk for maternal morbidity (eg, hypertensive urgency, preeclampsia, kidney failure, pulmonary edema, myocardial infarction, placental abruption, gestational diabetes, stroke, death) and poor fetal/neonatal outcomes (eg, growth restriction, preterm birth, congenital anomalies, stillbirth, perinatal death).1,2 Furthermore, cHTN during pregnancy increases long-term risks for development of cardiovascular, metabolic, and cerebrovascular disease.3 Therefore, effectively diagnosing and managing cHTN before, during, and after pregnancy is imperative for optimal maternal and child health.